Wedbush restated their outperform rating on shares of Scholar Rock (NASDAQ:SRRK – Free Report) in a research note published on Wednesday,RTT News reports. They currently have a $47.00 target price on ...

In a new research note, Truist said the FDA labelling is "largely as we expected [and] a favourable nod from the FDA" and could speed up the activation of new centres and patient onboarding time.

Truist Financial analyst Bill Chappell maintained a Buy rating on Energizer Holdings (ENR – Research Report) today. The company’s shares closed ...

Truist Securities sustained its optimistic stance on Amentum Holdings Inc. (NYSE:AMTM) following the company's release of favorable first-quarter 2025 results. With current revenue of $9.82 billion ...

Truist Financial analyst Srikripa Devarakonda reiterated a Buy rating on Nurix Therapeutics (NRIX – Research Report) today. The company’s ...

Truist Securities updated its outlook on Unum Group (NYSE: NYSE:UNM), raising the price target to $90 from the previous $75 while reiterating a Buy rating on the stock. This upgrade aligns with ...

Pacira BioSciences (PCRX) stock was upgraded by Truist based on a potential settlement to its patent dispute with eVenus ...

Bank stocks have had a solid January, and regional-bank stocks, and the ETF, look set to rise for the rest of the year.

If you click on links we provide, we may receive compensation. Truist Bank offers a simple CD account with several potential interest rate tiers Thomas J Catalano is a CFP and Registered ...

Investing.com -- Truist Securities lowered its price target on Chevron Corp (NYSE:CVX) to $160 from $164 on weaker-than-expected free cash flow and potential headwinds in the company's downstream ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...